基因型和治疗问题与"不寻常"的HCV1亚型
Cinzia Caudai1, Piera Pierotti2, Barbara Rossetti3
1Microbiology and Virology Unit, Siena University Hospital, Viale M. Bracci, 16, 53100, Siena, Italy. cinziacaudai@gmail.com.
概括
在非洲,罕见的C型肝炎病毒 (HCV) 亚型带来了治疗挑战. 分析NS5A区域有助于识别这些变异,并指导治疗选择以获得更好的结果.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 基因组学就是基因组学.
背景情况:
- 不常见的C型肝炎病毒 (HCV) 亚型,特别是非1a/1b亚型,在撒哈拉以南非洲经常被观察到.
- 这些HCV变种在NS5A区域内具有与耐药性相关的自然替代,这使得表征和治疗复杂化.
- 这些难以治疗的亚型的流行需要改进诊断和治疗策略.
研究的目的:
- 报告罕见亚型1g和1e的非洲患者的HCV基因组序列.
- 评估泛型治疗方案索福斯布维尔/韦尔帕塔斯维尔在治疗这些不寻常的HCV亚型中的有效性.
- 确定最适合的基因组区域,以便准确的亚型和明智的治疗决策.
主要方法:
- 来自两名非裔患者的HCV全基因组测序,这些人有异常的1g和1e亚型.
- 来自1亚型参考小组的HCV基因组序列分析.
- 利用多种生物信息学工具,精确地进行HCV亚型鉴定.
主要成果:
- 一名患有不寻常的1e亚型的患者经历了sofosbuvir/velpatasvir的治疗失败.
- 序列分析表明,NS5A区域在识别不寻常的HCV亚型方面非常有效.
- NS5A区域的多态性对于理解治疗耐药性至关重要.
结论:
- 在撒哈拉以南非洲普遍存在的异常HCV亚型的检测和表征中,NS5A区域是最可靠的目标.
- 精确的基于NS5A的亚型分类可以显著帮助选择适合这些具有挑战性的病例的治疗方案.
- 需要进一步的研究,以优化感染非1a/1b HCV亚型的患者的治疗策略.
相关概念视频
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...